P
P&K Skin Research Center Co Ltd
KOSDAQ:347740
P&K Skin Research Center Co Ltd
KOSDAQ:347740
Price:
2 400
KRW
-2.83%
Market Closed
Market Cap:
₩72B
Balance Sheet
Balance Sheet Decomposition
P&K Skin Research Center Co Ltd
P&K Skin Research Center Co Ltd
Balance Sheet Decomposition is not available for
P&K Skin Research Center Co Ltd
P&K Skin Research Center Co Ltd
Balance Sheet
P&K Skin Research Center Co Ltd
P&K Skin Research Center Co Ltd
Currency: KRW
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2 279
|
8 432
|
3 890
|
1 511
|
4 982
|
9 797
|
6 461
|
|
| Cash |
0
|
1
|
0
|
0
|
1
|
1
|
0
|
|
| Cash Equivalents |
2 279
|
8 431
|
3 890
|
1 511
|
4 981
|
9 796
|
6 461
|
|
| Short-Term Investments |
9 094
|
14 326
|
45 833
|
40 738
|
52 481
|
34 890
|
34 250
|
|
| Total Receivables |
1 118
|
1 455
|
1 191
|
1 467
|
2 584
|
5 908
|
5 414
|
|
| Accounts Receivables |
1 115
|
1 451
|
1 191
|
1 398
|
2 408
|
2 592
|
1 902
|
|
| Other Receivables |
3
|
4
|
0
|
69
|
176
|
3 316
|
3 511
|
|
| Other Current Assets |
37
|
113
|
337
|
302
|
312
|
483
|
2 039
|
|
| Total Current Assets |
12 529
|
24 325
|
51 252
|
44 018
|
60 359
|
51 079
|
48 164
|
|
| PP&E Net |
1 282
|
2 331
|
2 531
|
4 618
|
4 571
|
4 639
|
3 639
|
|
| PP&E Gross |
1 282
|
2 331
|
2 531
|
4 618
|
4 571
|
4 639
|
3 639
|
|
| Accumulated Depreciation |
1 878
|
2 256
|
3 191
|
4 252
|
5 585
|
7 225
|
7 755
|
|
| Intangible Assets |
90
|
0
|
0
|
39
|
165
|
198
|
198
|
|
| Long-Term Investments |
3 710
|
1 313
|
6 039
|
18 365
|
9 376
|
21 486
|
29 710
|
|
| Other Long-Term Assets |
29
|
0
|
70
|
54
|
68
|
5
|
328
|
|
| Total Assets |
17 641
N/A
|
27 969
+59%
|
59 892
+114%
|
67 094
+12%
|
74 539
+11%
|
77 407
+4%
|
82 040
+6%
|
|
| Liabilities | ||||||||
| Accrued Liabilities |
812
|
1 011
|
1 316
|
1 347
|
1 525
|
1 388
|
2 115
|
|
| Short-Term Debt |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
188
|
208
|
316
|
332
|
354
|
358
|
|
| Other Current Liabilities |
856
|
1 445
|
2 040
|
1 454
|
1 228
|
848
|
2 273
|
|
| Total Current Liabilities |
1 670
|
2 646
|
3 564
|
3 118
|
3 085
|
2 590
|
4 747
|
|
| Long-Term Debt |
0
|
748
|
622
|
728
|
409
|
314
|
165
|
|
| Deferred Income Tax |
0
|
26
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
36
|
79
|
|
| Other Liabilities |
13
|
52
|
79
|
181
|
238
|
264
|
272
|
|
| Total Liabilities |
1 683
N/A
|
3 472
+106%
|
4 265
+23%
|
4 027
-6%
|
3 732
-7%
|
3 204
-14%
|
5 104
+59%
|
|
| Equity | ||||||||
| Common Stock |
600
|
650
|
3 751
|
3 751
|
15 005
|
15 005
|
15 005
|
|
| Retained Earnings |
16 738
|
22 114
|
28 833
|
36 126
|
42 363
|
46 304
|
51 406
|
|
| Additional Paid In Capital |
0
|
3 114
|
24 423
|
24 423
|
13 095
|
13 095
|
13 095
|
|
| Treasury Stock |
1 380
|
1 380
|
1 380
|
1 307
|
0
|
611
|
2 996
|
|
| Other Equity |
0
|
0
|
0
|
74
|
344
|
410
|
426
|
|
| Total Equity |
15 957
N/A
|
24 497
+54%
|
55 626
+127%
|
63 067
+13%
|
70 807
+12%
|
74 203
+5%
|
76 935
+4%
|
|
| Total Liabilities & Equity |
17 641
N/A
|
27 969
+59%
|
59 892
+114%
|
67 094
+12%
|
74 539
+11%
|
77 407
+4%
|
82 040
+6%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
7
|
6
|
7
|
30
|
30
|
30
|
29
|
|
Switch to:
Switch to:
See Also
Discover More
